Robot‐assisted Percutaneous Radiofrequency Ablation for the Treatment of Osteoid Osteomas

Objective Percutaneous CT‐guided radiofrequency ablation (CT‐RFA) is a widely accepted procedure for treatment of osteoid osteomas. However, the application of CT‐RFA was restricted as a result of some drawbacks, such as radiation exposure, and inconvenience in general anesthesia. The primary aim of this study is to evaluate the safety and efficacy of intra‐operative TiRobot‐assisted percutaneous RFA of osteoid osteomas. Methods We retrospectively reviewed 21 medical files of patients who were treated with percutaneous RFA of osteoid osteomas guided by the TiRobot system in our institution between March 2021 and April 2022. The three‐dimensional images obtained by a 3D C‐arm intra‐operatively were sent to the TiRobot system. The puncture point and trajectory were designed. Then the guide pin was positioned to the lesion with the assistance of TiRobot and the biopsy sheath was inserted into the lesion through the guide pin. The tumor was biopsied for pathological examination. Then the RFA needle was inserted into the nidus through the biopsy sheath for thermal ablation. Data were extracted on the associated complications, the reduction in pain at 1 month and 1 year postoperatively assessed by the visual analogue scale (VAS). A paired t‐test was used to compare the pre‐operative and post‐operative VAS scores. Results The patients included 17 males and four females with a mean age of 19.5 ± 10.4 years (range 3–45 years). Lesions were located on the femur in nine cases, on the tibia in nine cases, on the humerus in one case, on the calcaneus in one case, and on the acetabulum in one case. TiRobot‐assisted percutaneous RFA was successfully performed on all 21 patients. There was no intra‐operative or post‐operative complications observed. Pathological diagnosis of osteoid osteoma was obtained in 11 patients, but the other 10 cases were not pathologically diagnosed. The mean follow‐up time was 18.8 months (range: 12–26 months).Post‐operative VAS scores were reduced significantly in all cases. The mean VAS score decreased from 6.5 pre‐operatively to 0.5 at 1 month post‐operatively and to 0.1 at 1 year post‐operatively. Conclusion As a reliable technique for localizing and resection of nidus, TiRobot‐assisted percutaneous RFA is a safe and effective option for the treatment of osteoid osteomas.